Marc Since

Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment

Cédric Lecoutey, Damien Hédou, Thomas Fréret et al. · Proceedings of the National Academy of Sciences · 2014 · 116 citations · Full text

Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment

Thomas Adnet, Anne‐Claire Groo, Céline Picard et al. · Pharmaceutics · 2020 · 73 citations · Full text

Evaluation of the versatile character of a nanoemulsion formulation

Emilie Gué, Marc Since, S. Ropars et al. · International Journal of Pharmaceutics · 2015 · 60 citations

Nanoparticles, Nanoemulsion Formulation, Microemulsion +2

Cyclic Poly(α-peptoid)s by Lithium bis(trimethylsilyl)amide (LiHMDS)-Mediated Ring-Expansion Polymerization: Simple Access to Bioactive Backbones

Pedro Salas‐Ambrosio, Antoine Tronnet, Marc Since et al. · Journal of the American Chemical Society · 2021 · 58 citations · Full text

Nongenotoxic 3-Nitroimidazo[1,2-<i>a</i>]pyridines Are NTR1 Substrates That Display Potent <i>in Vitro</i> Antileishmanial Activity

Cyril Fersing, Louise Basmaciyan, Clotilde Boudot et al. · ACS Medicinal Chemistry Letters · 2018 · 42 citations · Full text